115 related articles for article (PubMed ID: 2222722)
21. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A
J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550
[TBL] [Abstract][Full Text] [Related]
22. Effect of octadecylmethylglycerophosphocholine and hexadecylmethylglycerol on arachidonic acylation or release in macrophages.
Boucrot P; Lelain R; Petit JY; Welin L
J Lipid Mediat Cell Signal; 1994 May; 9(3):247-54. PubMed ID: 7921784
[TBL] [Abstract][Full Text] [Related]
23. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of a piperidine phospholipid.
Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
27. Stereospecific synthesis of antitumor active thioether PAF analogs.
Bhatia SK; Hajdu J
Lipids; 1991 Dec; 26(12):1424-30. PubMed ID: 1819745
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety.
Ukawa K; Imamiya E; Yamamoto H; Mizuno K; Tasaka A; Terashita Z; Okutani T; Nomura H; Kasukabe T; Hozumi M
Chem Pharm Bull (Tokyo); 1989 May; 37(5):1249-55. PubMed ID: 2630090
[TBL] [Abstract][Full Text] [Related]
29. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar head group, 2-(2-trimethylammonioethoxy)ethyl or a congeneric oligo(ethyleneoxy)ethyl group.
Ukawa K; Imamiya E; Yamamoto H; Aono T; Kozai Y; Okutani T; Nomura H; Honma Y; Hozumi M; Kudo I
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3277-85. PubMed ID: 2632072
[TBL] [Abstract][Full Text] [Related]
32. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.
Herrmann DB; Neumann HA
Lipids; 1987 Nov; 22(11):955-7. PubMed ID: 3444392
[TBL] [Abstract][Full Text] [Related]
34. The 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine causes a differential incorporation of hexadecanol into neutral ether ester glycerolipids of 2 variant cell lines of rat colon carcinoma.
Mjabri B; Boucrot P; Aubry J
Arch Int Physiol Biochim Biophys; 1992; 100(3):237-40. PubMed ID: 1382672
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of ether phospholipids and analogs in neoplastic cells.
Fleer EA; Unger C; Kim DJ; Eibl H
Lipids; 1987 Nov; 22(11):856-61. PubMed ID: 3444378
[TBL] [Abstract][Full Text] [Related]
36. Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.
Fujiwara K; Daniel LW; Modest EJ; Wallen CA
Cancer Chemother Pharmacol; 1994; 34(6):472-6. PubMed ID: 7923557
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties.
Morris-Natschke S; Surles JR; Daniel LW; Berens ME; Modest EJ; Piantadosi C
J Med Chem; 1986 Oct; 29(10):2114-7. PubMed ID: 3761326
[TBL] [Abstract][Full Text] [Related]
38. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.
Mollinedo F; Martínez-Dalmau R; Modolell M
Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770
[TBL] [Abstract][Full Text] [Related]
39. Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine observed by scanning electron microscopy.
Kaufmann-Kolle P; Fleer EA
Prog Exp Tumor Res; 1992; 34():47-58. PubMed ID: 1438802
[No Abstract] [Full Text] [Related]
40. Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
Fos E; Suesa N; Borras L; Lobato C; Banfi P; Gambetta RA; Zunino F; Mauleón D; Carganico G
J Med Chem; 1995 Mar; 38(7):1216-28. PubMed ID: 7707324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
